TD Cowen on TransMedics Amid 6% Gain: 'transplant logistics business experienced ~18.5% y/y growth'
Tweet Send to a Friend
TD Cowen analyst Joshua Jennings reiterated a Buy rating and $120.00 price target on TransMedics Group (NASDAQ: TMDX), according to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
